Loading clinical trials...
Loading clinical trials...
A Pharmacokinetic Study of SHR8554 Injection in Chinese Patients With Renal Insufficiency and Healthy Subjects
Conditions
Interventions
SHR8554 Injection
Locations
1
China
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
Start Date
September 20, 2022
Primary Completion Date
April 13, 2023
Completion Date
April 13, 2023
Last Updated
September 24, 2025
Lead Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions